Murphy Polly A.

Murphy Polly A. is listed in filings as Director at Atea Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 21, 2026, including purchase activity. Recent filings connect the profile to Atea Pharmaceuticals, Inc. (AVIR) and Celcuity Inc (CELC). The current snapshot covers public activity from Jun 18, 2024 to May 21, 2026. Reported amounts are shown as $25.4K to $120.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.